AI opens up new possibilities for the analysis of complex data in the life sciences. With a new Max Planck School should AI be more closely integrated with biomedical basic research in the future.

The goal of the graduate program is to educate a new generation of scientists who develop advanced AI methods for understanding biological systems and leverage their potential for medical applications.

The school is coordinated by Prof. Karsten Borgwardt, director at the Max Planck Institute for Biochemistry in Martinsried. Among the participating researchers is also Prof. Björn Ommer (LMU Munich), Chairman of the Bavarian AI Council, who contributes to the interdisciplinary alignment of the School with his expertise in the field of computer vision and machine learning.

Researchers from a total of 24 institutions across eleven federal states are involved. An important location will be Munich, with partners such as LMU, TU Munich, Helmholtz Munich, and the Max Planck Society.

First applications for doctoral positions are expected to be possible starting in the fall of 2026, with the first cohort likely starting in 2027.